- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Point-of-Care Testing (POCT) market will register a 9.8% CAGR in terms of revenue, the global market size will reach $ 30230 million by 2025, from $ 20830 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Point-of-Care Testing (POCT) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-Care Testing (POCT) market by type, application, key manufacturers and key regions and countries.
This study considers the Point-of-Care Testing (POCT) value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Urinalysis Testing
Others
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Clinics
Hospitals
Laboratory
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Nova Biomedical
Abbott
Siemens Healthcare
Danaher
Johnson & Johnson
BioMerieux
Ascensia
ARKRAY
Bio-Rad Laboratories
A. Menarini Diagnostics
Ortho Clinical Diagnostics
Abaxis (Zoetis)
Trividia Health
OraSure Technologies
Accriva
Chembio Diagnostics
Helena Laboratories
Quidel
Phamatech
Alfa Wassermann
ELITech Group
Response Biomedical
Trinity Biotech
Princeton BioMeditech
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Point-of-Care Testing (POCT) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Point-of-Care Testing (POCT) market by identifying its various subsegments.
Focuses on the key global Point-of-Care Testing (POCT) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Point-of-Care Testing (POCT) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Point-of-Care Testing (POCT) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Point-of-Care Testing (POCT) Consumption 2015-2025
2.1.2 Point-of-Care Testing (POCT) Consumption CAGR by Region
2.2 Point-of-Care Testing (POCT) Segment by Type
2.2.1 Blood Glucose Testing
2.2.2 Infectious Diseases Testing
2.2.3 Cardiac Markers Testing
2.2.4 Coagulation Testing
2.2.5 Pregnancy and Fertility Testing
2.2.6 Blood Gas/Electrolytes Testing
2.2.7 Urinalysis Testing
2.2.8 Others
2.3 Point-of-Care Testing (POCT) Consumption by Type
2.3.1 Global Point-of-Care Testing (POCT) Consumption Market Share by Type (2015-2020)
2.3.2 Global Point-of-Care Testing (POCT) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Point-of-Care Testing (POCT) Sale Price by Type (2015-2020)
2.4 Point-of-Care Testing (POCT) Segment by Application
2.4.1 Clinics
2.4.2 Hospitals
2.4.3 Laboratory
2.4.4 Others
2.5 Point-of-Care Testing (POCT) Consumption by Application
2.5.1 Global Point-of-Care Testing (POCT) Consumption Market Share by Type (2015-2020)
2.5.2 Global Point-of-Care Testing (POCT) Value and Market Share by Type (2015-2020)
2.5.3 Global Point-of-Care Testing (POCT) Sale Price by Type (2015-2020)
3 Global Point-of-Care Testing (POCT) by Company
3.1 Global Point-of-Care Testing (POCT) Sales Market Share by Company
3.1.1 Global Point-of-Care Testing (POCT) Sales by Company (2018-2020)
3.1.2 Global Point-of-Care Testing (POCT) Sales Market Share by Company (2018-2020)
3.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Company
3.2.1 Global Point-of-Care Testing (POCT) Revenue by Company (2018-2020)
3.2.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Company (2018-2020)
3.3 Global Point-of-Care Testing (POCT) Sale Price by Company
3.4 Global Point-of-Care Testing (POCT) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Point-of-Care Testing (POCT) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Point-of-Care Testing (POCT) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Point-of-Care Testing (POCT) by Regions
4.1 Point-of-Care Testing (POCT) by Regions
4.2 Americas Point-of-Care Testing (POCT) Consumption Growth
4.3 APAC Point-of-Care Testing (POCT) Consumption Growth
4.4 Europe Point-of-Care Testing (POCT) Consumption Growth
4.5 Middle East & Africa Point-of-Care Testing (POCT) Consumption Growth
5 Americas
5.1 Americas Point-of-Care Testing (POCT) Consumption by Countries
5.1.1 Americas Point-of-Care Testing (POCT) Consumption by Countries (2015-2020)
5.1.2 Americas Point-of-Care Testing (POCT) Value by Countries (2015-2020)
5.2 Americas Point-of-Care Testing (POCT) Consumption by Type
5.3 Americas Point-of-Care Testing (POCT) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Point-of-Care Testing (POCT) Consumption by Regions
6.1.1 APAC Point-of-Care Testing (POCT) Consumption by Regions (2015-2020)
6.1.2 APAC Point-of-Care Testing (POCT) Value by Regions (2015-2020)
6.2 APAC Point-of-Care Testing (POCT) Consumption by Type
6.3 APAC Point-of-Care Testing (POCT) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Point-of-Care Testing (POCT) by Countries
7.1.1 Europe Point-of-Care Testing (POCT) Consumption by Countries (2015-2020)
7.1.2 Europe Point-of-Care Testing (POCT) Value by Countries (2015-2020)
7.2 Europe Point-of-Care Testing (POCT) Consumption by Type
7.3 Europe Point-of-Care Testing (POCT) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Point-of-Care Testing (POCT) by Countries
8.1.1 Middle East & Africa Point-of-Care Testing (POCT) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Point-of-Care Testing (POCT) Value by Countries (2015-2020)
8.2 Middle East & Africa Point-of-Care Testing (POCT) Consumption by Type
8.3 Middle East & Africa Point-of-Care Testing (POCT) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Point-of-Care Testing (POCT) Distributors
10.3 Point-of-Care Testing (POCT) Customer
11 Global Point-of-Care Testing (POCT) Market Forecast
11.1 Global Point-of-Care Testing (POCT) Consumption Forecast (2021-2025)
11.2 Global Point-of-Care Testing (POCT) Forecast by Regions
11.2.1 Global Point-of-Care Testing (POCT) Forecast by Regions (2021-2025)
11.2.2 Global Point-of-Care Testing (POCT) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Point-of-Care Testing (POCT) Forecast by Type
11.8 Global Point-of-Care Testing (POCT) Forecast by Application
12 Key Players Analysis
12.1 Roche
12.1.1 Company Information
12.1.2 Point-of-Care Testing (POCT) Product Offered
12.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Roche Latest Developments
12.2 Nova Biomedical
12.2.1 Company Information
12.2.2 Point-of-Care Testing (POCT) Product Offered
12.2.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Nova Biomedical Latest Developments
12.3 Abbott
12.3.1 Company Information
12.3.2 Point-of-Care Testing (POCT) Product Offered
12.3.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Abbott Latest Developments
12.4 Siemens Healthcare
12.4.1 Company Information
12.4.2 Point-of-Care Testing (POCT) Product Offered
12.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Siemens Healthcare Latest Developments
12.5 Danaher
12.5.1 Company Information
12.5.2 Point-of-Care Testing (POCT) Product Offered
12.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Danaher Latest Developments
12.6 Johnson & Johnson
12.6.1 Company Information
12.6.2 Point-of-Care Testing (POCT) Product Offered
12.6.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Johnson & Johnson Latest Developments
12.7 BioMerieux
12.7.1 Company Information
12.7.2 Point-of-Care Testing (POCT) Product Offered
12.7.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 BioMerieux Latest Developments
12.8 Ascensia
12.8.1 Company Information
12.8.2 Point-of-Care Testing (POCT) Product Offered
12.8.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Ascensia Latest Developments
12.9 ARKRAY
12.9.1 Company Information
12.9.2 Point-of-Care Testing (POCT) Product Offered
12.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 ARKRAY Latest Developments
12.10 Bio-Rad Laboratories
12.10.1 Company Information
12.10.2 Point-of-Care Testing (POCT) Product Offered
12.10.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Bio-Rad Laboratories Latest Developments
12.11 A. Menarini Diagnostics
12.11.1 Company Information
12.11.2 Point-of-Care Testing (POCT) Product Offered
12.11.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 A. Menarini Diagnostics Latest Developments
12.12 Ortho Clinical Diagnostics
12.12.1 Company Information
12.12.2 Point-of-Care Testing (POCT) Product Offered
12.12.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Ortho Clinical Diagnostics Latest Developments
12.13 Abaxis (Zoetis)
12.13.1 Company Information
12.13.2 Point-of-Care Testing (POCT) Product Offered
12.13.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Abaxis (Zoetis) Latest Developments
12.14 Trividia Health
12.14.1 Company Information
12.14.2 Point-of-Care Testing (POCT) Product Offered
12.14.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Trividia Health Latest Developments
12.15 OraSure Technologies
12.15.1 Company Information
12.15.2 Point-of-Care Testing (POCT) Product Offered
12.15.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 OraSure Technologies Latest Developments
12.16 Accriva
12.16.1 Company Information
12.16.2 Point-of-Care Testing (POCT) Product Offered
12.16.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Accriva Latest Developments
12.17 Chembio Diagnostics
12.17.1 Company Information
12.17.2 Point-of-Care Testing (POCT) Product Offered
12.17.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Chembio Diagnostics Latest Developments
12.18 Helena Laboratories
12.18.1 Company Information
12.18.2 Point-of-Care Testing (POCT) Product Offered
12.18.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Helena Laboratories Latest Developments
12.19 Quidel
12.19.1 Company Information
12.19.2 Point-of-Care Testing (POCT) Product Offered
12.19.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Quidel Latest Developments
12.20 Phamatech
12.20.1 Company Information
12.20.2 Point-of-Care Testing (POCT) Product Offered
12.20.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Phamatech Latest Developments
12.21 Alfa Wassermann
12.21.1 Company Information
12.21.2 Point-of-Care Testing (POCT) Product Offered
12.21.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 Alfa Wassermann Latest Developments
12.22 ELITech Group
12.22.1 Company Information
12.22.2 Point-of-Care Testing (POCT) Product Offered
12.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 ELITech Group Latest Developments
12.23 Response Biomedical
12.23.1 Company Information
12.23.2 Point-of-Care Testing (POCT) Product Offered
12.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.23.4 Main Business Overview
12.23.5 Response Biomedical Latest Developments
12.24 Trinity Biotech
12.24.1 Company Information
12.24.2 Point-of-Care Testing (POCT) Product Offered
12.24.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.24.4 Main Business Overview
12.24.5 Trinity Biotech Latest Developments
12.25 Princeton BioMeditech
12.25.1 Company Information
12.25.2 Point-of-Care Testing (POCT) Product Offered
12.25.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2018-2020)
12.25.4 Main Business Overview
12.25.5 Princeton BioMeditech Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Point-of-Care Testing (POCT) Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major P
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
